The Chemistry and Biology of Heparan Sulfate'program project consists of several supporting Cores. This document describes the 'Glycoscience Skills Development Core'. This Core will be headed by Drs. Desai and Balagurunathan with each project leader playing an important role in the establishment and operation of the core. The PLs will form the primary body that co-ordinates efforts on the development of skills. At least six scientists, some already engaged in research with the Pis, will form the focus group for glycoscience skills engagement. These six individuals will work under the direct supervision of their PLs. In addition, the PLs will train new graduate and postdoctoral students. Finally, the six senior scientists will be expected to engage additional junior members (post-doctoral, graduate or undergraduate students) of the laboratory so as to cultivate supervisory skills for a future independent faculty position. Overall, the four teams of the PEG expect to train six senior scientists and 10 new students (postdoctoral and graduate) in glycoscience research. The Core will organize a yearly glycan skills boot camp, didactic teaching sessions, workshops on research and teaching techniques, workshop on proposal writing and reviewing, and train participants in responsible conduct of research. Among the glycan skills that will be specifically taught include the glycan isolation, separation and preparation skills, glycan structure and analysis skills, glycan molecular modeling and simulation skills, glycan biophysical and biochemical interactions skills, glycan biology skills and glycan histopathology and immunology skills.

Public Health Relevance

The Glycan Skills Development Core will support the The Chemistry and Biology of Heparan Sulfate'program project on all aspects of skills development. The PEG proposes design of heparan sulfate molecules that are potentially useful in the treatment of thrombotic and inflammatory disorders as well as resolve coagulation problems observed in during pig to non-human primate xenotransplantation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
1P01HL107152-01
Application #
8184153
Study Section
Special Emphasis Panel (ZHL1-CSR-H (F1))
Project Start
Project End
Budget Start
2011-09-23
Budget End
2012-07-31
Support Year
1
Fiscal Year
2011
Total Cost
$112,125
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Brown, Aaron J; Sepuru, Krishna Mohan; Sawant, Kirti V et al. (2017) Platelet-Derived Chemokine CXCL7 Dimer Preferentially Exists in the Glycosaminoglycan-Bound Form: Implications for Neutrophil-Platelet Crosstalk. Front Immunol 8:1248
Zhang, Haohai; Chan, Leo Li-Ying; Rice, William et al. (2017) Novel high-throughput cell-based hybridoma screening methodology using the Celigo Image Cytometer. J Immunol Methods 447:23-30
Iwase, Hayato; Liu, Hong; Li, Tao et al. (2017) Therapeutic regulation of systemic inflammation in xenograft recipients. Xenotransplantation 24:
Jiang, Z Gordon; Sandhu, Bynvant; Feldbr├╝gge, Linda et al. (2017) Serum Activity of Macrophage-Derived Adenosine Deaminase 2 Is Associated With Liver Fibrosis in Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol :
Brown, Aaron J; Sepuru, Krishna Mohan; Rajarathnam, Krishna (2017) Structural Basis of Native CXCL7 Monomer Binding to CXCR2 Receptor N-Domain and Glycosaminoglycan Heparin. Int J Mol Sci 18:
Zheng, Shuo; Kummarapurugu, Apparao B; Afosah, Daniel K et al. (2017) 2-O, 3-O Desulfated Heparin Blocks High Mobility Group Box 1 Release by Inhibition of p300 Acetyltransferase Activity. Am J Respir Cell Mol Biol 56:90-98
Longhi, Maria Serena; Vuerich, Marta; Kalbasi, Alireza et al. (2017) Bilirubin suppresses Th17 immunity in colitis by upregulating CD39. JCI Insight 2:
Iwase, Hayato; Hara, Hidetaka; Ezzelarab, Mohamed et al. (2017) Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts. Xenotransplantation 24:
Bi, Yiling; Might, Matthew; Vankayalapati, Hariprasad et al. (2017) Repurposing of Proton Pump Inhibitors as first identified small molecule inhibitors of endo-?-N-acetylglucosaminidase (ENGase) for the treatment of NGLY1 deficiency, a rare genetic disease. Bioorg Med Chem Lett 27:2962-2966
Iwase, Hayato; Liu, Hong; Schmelzer, Eva et al. (2017) Transplantation of hepatocytes from genetically engineered pigs into baboons. Xenotransplantation 24:

Showing the most recent 10 out of 123 publications